AJP - Lung Columbus Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Lung Cell Mol Physiol 293: L77-L83, 2007. First published March 23, 2007; doi:10.1152/ajplung.00282.2006
1040-0605/07 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/1/L77    most recent
00282.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brass, D. M.
Right arrow Articles by Schwartz, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brass, D. M.
Right arrow Articles by Schwartz, D. A.

CD14 is an essential mediator of LPS-induced airway disease

David M. Brass,1 John W. Hollingsworth,1,2 Erin McElvania-Tekippe,1 Stavros Garantziotis,1,2 Imtaz Hossain,1 and David A. Schwartz1

1National Institute of Environmental Health Sciences, Research Triangle Park, and 2Division of Pulmonary, Allergy, and Critical Care Medicine, Duke University Medical Center, Durham, North Carolina

Submitted 26 July 2006 ; accepted in final form 22 March 2007


   ABSTRACT
TOP
 ABSTRACT
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Chronic lipopolysaccharide (LPS) inhalation in rodents recapitulates many classic features of chronic obstructive pulmonary disease seen in humans, including airways hyperresponsiveness, neutrophilic inflammation, cytokine production in the lung, and small airways remodeling. CD14-deficient mice (C57BL/6CD14–/–) have an altered response to systemic LPS, and yet the role of CD14 in the response to inhaled LPS has not been defined. We observed that C57BL/6CD14–/– mice demonstrate no discernable physiological or inflammatory response to a single LPS inhalation challenge. However, the physiological (airways hyperresponsiveness) and inflammatory (presence of neutrophils and TNF-{alpha} in whole lung lavage fluid) responsiveness to inhaled LPS in C57BL/6CD14–/– mice was restored by instilling soluble CD14 intratracheally. Intratracheal instillation of wild-type macrophages into C57BL/6CD14–/– mice restored neutrophilic inflammation only and failed to restore airways hyperresponsiveness or TNF-{alpha} protein in whole lung lavage. These findings demonstrate that CD14 is critical to LPS-induced airway disease and that macrophage CD14 is sufficient to initiate neutrophil recruitment into the airways but that CD14 may need to interact with other cell types as well for the development of airways hyperresponsiveness and for cytokine production.

lipopolysaccharide; airways hyperresponsiveness; tumor necrosis factor; inflammation

CHRONIC OBSTRUCTIVE PULMONARY disease (COPD) has emerged as the fourth leading cause of death in the United States (1). In this disease, neutrophils are recruited to the airway in response to both cigarette smoke and bacterial products. Inhalation of bacterial endotoxin or lipopolysaccharide (LPS) causes acute and chronic airway disease in mice (5, 12, 23), and chronic LPS inhalation serves as a model of human environmental airway disease and COPD. Additionally, environmental LPS can contribute to exacerbations of allergic asthma (29, 30) increasing the likelihood of uncontrolled disease and increased health care costs. Understanding the acute response to inhaled LPS will provide important insight into the management of chronic inflammatory diseases such as asthma and COPD.

The response to inhaled LPS absolutely requires Toll-like receptor 4 (TLR4) (21) and at low LPS doses is dependent on LPS-binding protein (LBP) for a complete acute response to inhaled LPS (6). TLR4 and LBP are also required for the development of airway remodeling and concomitant persistent airways hyperresponsiveness (AHR) to inhaled methacholine (MCh) consequent to chronic LPS exposure. However, one must ask whether other components that recognize LPS and initiate TLR4 activation are essential to the airway response to LPS.

One such component of the LPS response, CD14, has been shown to be important in the in vitro response to LPS and exists as a glycosylphosphatidylinositol-linked surface receptor found on myeloid cells (15, 45) or in soluble form (2). In vitro, LPS-responsive cells lacking membrane-bound CD14 (mCD14) become sensitive to low concentrations of LPS in the presence of soluble CD14 (sCD14) (11). sCD14 appears to derive from monocytes (3) as well as from the liver (20, 40) and is found in normal serum at microgram concentrations (2). In mice, CD14 deficiency imparts resistance to LPS administered intravenously (10). It has also recently been shown that the response to low-dose LPS instilled intratracheally is completely dependent on CD14, whereas at higher doses the response is also dependent on CD11b (24). Additionally, it has also been demonstrated that intravenous injection of an anti-CD14 antibody attenuates LPS-induced lung injury (41). We therefore investigated the role of sCD14 and mCD14 on macrophages in the development of inflammation and AHR in response to inhaled LPS to better understand the biology of chronic LPS inhalation as a model of environmental airways disease and COPD.


   MATERIALS AND METHODS
TOP
 ABSTRACT
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Animals

Five or six male C57BL/6 mice (Jackson Laboratories, Bar Harbor, ME) and five or six male CD14–/– mice at 8 wk of age were used for each group in this study. Experimental protocols were reviewed and approved by the Institutional Animal Care and Use Committee at Duke University Medical Center and were carried out in accordance with the standards established by the United States Animal Welfare Acts.

LPS Preparation and Aerosol Exposures

LPS was purchased as purified lyophilized powder [lot 110K4060; 25 mg; 30,000,000 endotoxin units (EU)/mg] prepared by phenol extraction from Escherichia coli serotype 0111:B4 from Sigma. LPS was reconstituted with 10 ml of sterile PBS. Immediately before use, LPS stock was diluted in 200 ml of PBS for aerosolization.

sCD14 Instillation

sCD14 was purchased from R&D Systems, Minneapolis, MN (cat. no. 982-CD-100) and resuspended in endotoxin-free PBS. A total of either 15 or 8 µg per mouse was delivered in 40 µl of endotoxin-free PBS via oropharyngeal aspiration (9).

LPS Exposure

Mice were placed in individual compartments of stainless steel wire cage exposure racks in 135-l Hinner-style exposure chambers. Animals were exposed for 2.5 h, and LPS solution was aerosolized with a constant output atomizer (model 3076; TSI, Minneapolis, MN) with all output directed to the exposure chamber. Filtered, dehumidified air was supplied to the nebulizer at 30 psi gauge pressure. The exposure chamber was vented at a flow rate of 35.0 l/min.

LPS Assay

The airborne concentration of LPS was assessed by sampling 80 l of air drawn from the exposure chamber through 25-mm binder-free glass fiber filters (Gelman Sciences, Ann Arbor, MI) held within a 25-mm polypropylene inline air-sampling filter holder (Gelman Sciences) and tested for LPS concentration by using a chromogenic Limulus amebocyte lysate assay (QCL-1000; BioWhittaker, Walkersville, MD) according to the manufacturer's instructions. LPS aerosol concentrations were 4–6 µg/m3 of air.

Airway Physiology

Whole body plethysmography. Airway responsiveness to inhaled MCh challenge was assessed in unrestrained, unanesthetized mice by using whole body plethysmography (Buxco Electronics, Troy, NY). Lung function was evaluated at 0, 5, 10, and 20 mg/ml of inhaled MCh.

Airway Pressure Time Index

Mice were anesthetized with pentobarbital sodium (60 mg/kg) intraperitoneally. Airway pressure (43) was measured by a differential pressure transducer connected to the side port of a surgically inserted tracheostomy cannula used to ventilate the animals with 6–8 ml/kg total volume at 125 breaths per minute. Neuromuscular blockade was accomplished with doxacurium chloride (0.25 mg/kg) and assessed by spontaneous respiratory efforts. Intravenous MCh (25, 100, and 250 µg/kg) was administered into the jugular vein.

Adoptive Transfer

Adoptive transfer of alveolar macrophages was achieved by harvesting whole lung lavage from five unexposed donor animals per recipient and pooling cells. A total of 2 x 105 cells, which comprised of more than 98% alveolar macrophages, were then intratracheally instilled into each recipient animal anesthetized with isoflurane. Five adoptive transfer recipient animals per group were then phenotyped for their response to inhaled LPS.

Whole Lung Lavage

Mice were euthanized by CO2 inhalation, and lungs were lavaged through PE-90 tubing with 6.0 ml of sterile saline, 1 ml at a time, at a pressure of 20 cmH2O. The lavage fluid was centrifuged for 5 min at 200 g, the supernatant was decanted and stored at –70°C for further use, and the cell pellet was resuspended with Hanks’ balanced salt solution (without Ca or Mg). A small aliquot of this resuspension was used to count total lavaged cells per animal with a hemocytometer. One hundred microliters of the cell suspension were spun onto a slide with a cytocentrifuge (Shandon, Southern Sewickley, PA). Cells were stained with Hema-3 (Biochemical Sciences, Swedesboro, NJ) stain for differentials, air-dried, and covered with a coverslip with Cytoseal (Stephens Scientific, Kalamazoo, MI).

Cytokine Analysis in Whole Lung Lavage Fluid

ELISA for TNF-{alpha} was performed on aliquots of lung lavage fluid from each animal in duplicate according to the manufacturer's instructions (R&D Systems). The lower limit of detection was 5.1 pg/ml.

Statistical Analyses

All data are expressed as means ± SE. For all groups, the total and differential cell counts from lung lavage fluid, the airway responsiveness to MCh challenge, and TNF-{alpha} protein expression were compared between C57BL/6 and C57BL/6CD14–/– mice. The differences between variables in each comparison were analyzed by Mann-Whitney U test. Probability values of P < 0.05 (2-tailed) were considered statistically significant.


   RESULTS
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 GRANTS
 REFERENCES
 
C57BL/6CD14–/– Mice are Unresponsive to Inhaled LPS

We first asked whether C57BL/6CD14–/– mice are responsive to inhaled LPS. To address this, we exposed C57BL/6 and C57BL/6CD14–/– mice to LPS by inhalation for 2.5 h. In unexposed C57BL/6 and C57BL/6CD14–/– mice, there was no difference between groups in total cells or percent neutrophils in whole lung lavage cells (Fig. 1A). Of the mice from the LPS-exposed groups, only the C57BL/6 mice had an increase in total cells in whole lung lavage or in the percentage of neutrophils in the differential counts (Fig. 1A).


Figure 1
View larger version (21K):
[in this window]
[in a new window]

  		Fig. 1. CD14-deficient mice (C57BL/6CD14–/–) are unresponsive to inhaled LPS. A: total cells (left) and % neutrophils (PMN; right) in whole lung lavage fluid from LPS-exposed and air-exposed C57BL/6 and C57BL/6CD14–/– mice (CD14–/–). B: whole body plethysmography (Penh) from LPS-exposed and air-exposed C57BL/6 and C57BL/6CD14–/– mice. n = 4 animals per group. Data are means ± SE. *P < 0.05 significantly reduced vs. LPS-exposed C57BL/6 mice. #P < 0.05 significantly elevated vs. unexposed C57BL/6CD14–/– mice. MCh, methacholine.

 
We next asked whether C57BL/6CD14–/– mice develop AHR to inhaled MCh challenge after a single acute LPS exposure. Before LPS inhalation, there was no difference between C57BL/6 and C57BL/6CD14–/– mice in their responsiveness to inhaled MCh. After LPS inhalation, the C57BL/6 mice had AHR as measured by whole body plethysmography at all concentrations of MCh. C57BL/6CD14–/– mice had an elevated response to inhaled MCh only at the 20 mg/ml concentration (Fig. 1B).

Acute LPS inhalation causes an increase in cytokine protein levels in whole lung lavage fluid (44). We asked whether C57BL/6CD14–/– mice respond to inhaled LPS with increases in TNF-{alpha} in the lavage fluid. There was no detectable TNF-{alpha} protein in whole lung lavage fluid in either C57BL/6 or C57BL/6CD14–/– mice exposed to air alone (Table 1). Immediately after a single acute LPS inhalation challenge, only C57BL/6 mice had detectable TNF-{alpha} protein in the lavage fluid (Table 1).


View this table:
[in this window]
[in a new window]

  		Table 1. TNF-{alpha} in whole lung lavage fluid measured by ELISA

 
sCD14 Restores Inflammation and AHR to C57BL/6CD14–/– Mice in Response to Inhaled LPS

We asked whether sCD14 instilled into the lungs of C57BL/6CD14–/– mice via oropharyngeal aspiration would restore all of the features of the response [polymorphonuclear leukocytes (PMNs), cytokines, and AHR] to inhaled LPS observed in wild-type C57BL/6 mice. To answer this question, we instilled 15 µg of sCD14 into the lungs of C57BL/6CD14–/– mice and exposed them to either inhaled LPS or filtered air for 2.5 h. There was no difference in the concentration of inflammatory cells in the lavage fluid between air-exposed C57BL/6 mice or C57BL/6CD14–/– mice receiving sCD14 or LPS-exposed C57BL/6CD14–/– mice receiving vehicle alone (Fig. 2A). However, C57BL/6CD14–/– mice receiving intratracheally instilled sCD14 had significantly elevated total cells in whole lung lavage fluid, and the majority of these cells were neutrophils (Fig. 2A).


Figure 2
View larger version (23K):
[in this window]
[in a new window]

  		Fig. 2. Soluble CD14 (sCD14) restores the complete response to inhaled LPS in C57BL/6CD14–/– mice. A: total cells (left) and % PMN (right) in whole lung lavage fluid from LPS-exposed and air-exposed C57BL/6 and C57BL/6CD14–/– mice (CD14–/–) receiving either sCD14 or vehicle (Veh) alone. B: whole body plethysmography (Penh) from LPS-exposed and air-exposed C57BL/6 and C57BL/6CD14–/– mice receiving either sCD14 or vehicle alone. C: airway pressure time index on C57BL/6CD14–/– mice receiving either sCD14 or vehicle alone. n = 5 mice per group. Data are means ± SE. *P < 0.05 significantly elevated vs. LPS-exposed C57BL/6CD14–/– mice receiving vehicle alone; #P < 0.05 significantly elevated compared with air-exposed C57BL/6 mice.

 
We next asked whether sCD14 instilled via oropharyngeal aspiration would restore MCh responsiveness to C57BL/6CD14–/– mice exposed to inhaled LPS. C57BL/6CD14–/– mice that received vehicle alone and were exposed to inhaled LPS were not different from unexposed mice in their responsiveness to inhaled MCh challenge (Fig. 2B). C57BL/6 mice and C57BL/6CD14–/– mice receiving sCD14 had similar responses to inhaled MCh challenge and were significantly elevated compared with control mice (Fig. 2B). This result was confirmed by airway pressure time index (Fig. 2C).

We asked whether sCD14 instilled into the lungs of C57BL/6CD14–/– mice would restore their ability to produce TNF-{alpha} protein in whole lung lavage fluid after acute LPS inhalation challenge. Air-exposed C57BL/6CD14–/– mice receiving sCD14 had no measurable TNF-{alpha} in whole lung lavage fluid, and LPS-exposed C57BL/6CD14–/– mice receiving vehicle alone had no TNF-{alpha} in whole lung lavage fluid either (Table 2). Oropharyngeally administered sCD14 restored the ability of C57BL/6CD14–/– mice to produce TNF-{alpha} protein in their lungs in response to inhaled LPS (Table 2).


View this table:
[in this window]
[in a new window]

  		Table 2. TNF-{alpha} in whole lung lavage fluid measured by ELISA

 
sCD14 Enhances the Response to Inhaled LPS in C57BL/6 Mice

Because the response to bacterial endotoxin is so important in the response to gram-negative infection in mammals, we asked whether exogenously added sCD14 would enhance or attenuate the airway inflammatory response to inhaled LPS in C57BL/6 mice. To address this question, we instilled 5, 15, or 25 µg of sCD14 into the lungs of C57BL/6 mice via oropharyngeal aspiration before LPS inhalation challenge. LPS-exposed C57BL/6 mice receiving 25 µg of sCD14 had significantly enhanced pulmonary inflammation compared with LPS-exposed C57BL/6 mice receiving vehicle alone (Fig. 3A, left). The profile of cells in whole lung lavage remained unchanged, however, with the majority being PMNs (Fig. 3A, right).


Figure 3
View larger version (11K):
[in this window]
[in a new window]

  		Fig. 3. sCD14 enhances the inflammatory response to inhaled LPS in C57BL/6 mice. Shown are the total cells (left) and %PMN (right) in whole lung lavage fluid from LPS-exposed C57BL/6 mice receiving either vehicle or sCD14 at the indicated concentrations. n = 5 animals per group. Data are means ± SE. *P < 0.05 significantly elevated vs. LPS-exposed C57BL/6 mice receiving vehicle alone.

 
We also asked whether sCD14 instilled into the lungs of C57BL/6 mice would affect TNF-{alpha} protein production in whole lung lavage fluid after acute LPS inhalation challenge. Air-exposed C57BL/6 mice receiving sCD14 had no measurable TNF-{alpha} in whole lung lavage fluid. Exogenously added sCD14 had no effect on TNF-{alpha} protein concentration in the lung despite the increased cellularity at the 25 µg dose of sCD14 (Table 3).


View this table:
[in this window]
[in a new window]

  		Table 3. TNF-{alpha} in whole lung lavage fluid measured by ELISA

 
Oropharyngeal Instillation of Alveolar Macrophages from C57BL/6 Mice into C57BL/6CD14–/– Mice Restores Neutrophilic Inflammation but Not Cytokine Production or AHR in Response to Inhaled LPS

We asked whether CD14 expression on macrophages alone would restore the ability of C57BL/6CD14–/– mice to respond to inhaled LPS. Therefore, we adoptively transferred naïve wild-type alveolar macrophages into the lungs of C57BL/6CD14–/– mice via oropharyngeal aspiration. Air-exposed C57BL/6CD14–/– mice receiving wild-type macrophages had pulmonary cellularity that was not different from naïve C57BL/6 mice (Figs. 4A and 1A). LPS-exposed C57BL/6CD14–/– mice receiving vehicle alone had pulmonary inflammation that was significantly elevated over unexposed mice receiving wild-type macrophages. However, LPS-exposed C57BL/6CD14–/– mice receiving wild-type macrophages had pulmonary inflammation that was significantly elevated compared with C57BL/6CD14–/– mice receiving either wild-type macrophages and exposed to air alone or vehicle alone and exposed to LPS (Fig. 4A).


Figure 4
View larger version (22K):
[in this window]
[in a new window]

  		Fig. 4. Oropharyngeal instillation of alveolar macrophages from C57BL/6 mice into C57BL/6CD14–/– mice only partially restores responsiveness to inhaled LPS. A: total cells (left) and %PMN (right) in whole lung lavage fluid from LPS-exposed C57BL/6 mice and LPS-exposed and air-exposed C57BL/6CD14–/– mice (CD14–/–) receiving either wild-type macrophages (w/t M{phi}) via oropharyngeal aspiration or vehicle alone. B: whole body plethysmography (Penh) from LPS-exposed C57BL/6 mice and LPS-exposed and air-exposed CD14–/– mice receiving either wild-type macrophages via oropharyngeal aspiration or vehicle alone. n = 5 mice per group. Data are means ± SE. *P < 0.05 significantly elevated vs. air-exposed CD14–/– mice receiving vehicle alone; **P < 0.05 significantly elevated vs. air-exposed CD14–/– mice receiving wild-type macrophages or LPS-exposed CD14–/– mice receiving vehicle alone; #P < 0.05 significantly elevated vs. all other groups.

 
We next asked whether CD14 expression on macrophages alone is sufficient to reconstitute the physiological response to inhaled LPS. C57BL/6CD14–/– mice receiving wild-type macrophages and exposed to inhaled LPS demonstrate a trend toward increased response to MCh but were not statistically different from C57BL/6CD14–/– mice receiving wild-type macrophages exposed to air or from LPS-exposed C57BL/6CD14–/– mice receiving vehicle alone in their responsiveness to inhaled MCh (Fig. 4B).

C57BL/6CD14–/– mice receiving wild-type macrophages and exposed to LPS had no detectable TNF-{alpha} in whole lung lavage fluid (Table 4), and neither did C57BL/6CD14–/– mice receiving wild-type macrophages and exposed to air nor C57BL/6CD14–/– mice receiving vehicle alone and exposed to LPS (Table 4).


View this table:
[in this window]
[in a new window]

  		Table 4. TNF-{alpha} in whole lung lavage fluid measured by ELISA

 

   DISCUSSION
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
GRANTS
 REFERENCES
 
The findings presented here demonstrate that CD14 is required for the physiological and biological response to inhaled LPS and that exogenously added sCD14 is sufficient to reconstitute the physiological (AHR) and biological (inflammation and cytokines) response to inhaled LPS in C57BL/6CD14–/– mice. Furthermore, although CD14 expression on macrophages alone can partially reconstitute the ability of C57BL/6CD14–/– mice to mount a neutrophilic inflammatory response to inhaled LPS, in our hands, macrophage expression of CD14 is not sufficient for the development of AHR or TNF-{alpha} production. We also show that augmenting the endogenous concentration of sCD14 enhances neutrophilic inflammation in response to inhaled LPS.

The role of endogenous mCD14 and sCD14 in the lung in the response to inhaled LPS has not been fully elucidated. Systemically, it has been shown that transgenic mice that overexpress human mCD14 have significantly increased sensitivity to LPS (8). Our dose response experiment in wild-type mice is consistent with this result (Fig. 3). Additionally, CD14-deficient mice are hyporesponsive to intraperitoneal LPS and resistant to experimental gram-negative sepsis (16). In the lung, it has recently been shown that the response to low-dose LPS instilled intratracheally is completely dependent on CD14, whereas at higher doses, the response is also dependent on CD11b (24). Our low-dose study is completely consistent with this finding. Additionally, it has also been demonstrated that intravenous injection of an anti-CD14 antibody attenuates LPS-induced lung injury (41). Two opposing functions have been described for sCD14. It has been shown that sCD14 can either compete with mCD14 for LPS binding (17, 18, 34, 35), thus limiting the signaling capability of LPS, or it can enable LPS-induced activation of cells that do not express mCD14 such as endothelial, epithelial, and smooth muscle cells (11, 19, 28, 32, 33). In vitro sCD14 can either enhance or inhibit the responses of cells in a concentration-dependent manner (13, 17, 35), and in vivo it has been shown that recombinant bovine or recombinant human sCD14 injected intraperitoneally protects mice from experimental LPS-induced shock (26, 39) suggesting that this sCD14 competes with endogenous mCD14 for LPS binding. We show that sCD14 renders C57BL/6CD14–/– mice sensitive to inhaled LPS and also enhances the sensitivity of C57BL/6 mice, and thus these observations and our data taken together suggest that CD14 is an enhancer of the response to low-dose inhaled LPS.

Macrophages are the first line of defense against pathogenic stimuli in the lung. The elaboration of cytokines such at TNF-{alpha}, IL-1, and IL-6 serve to amplify and regulate this response (27, 42). However, little is known about the exact mechanism by which macrophages recruit PMNs and other inflammatory cells to the lung, and even less is known about the relationship between these events and AHR. In a previous study (22) and in the present work, we have used adoptive transfer to attempt to address this question. In our hands, we typically recover up to 3 x 105 alveolar macrophages from whole lung lavage of naïve C57BL/6 mice; thus in our studies, we instilled 2 x 105 wild-type alveolar macrophages. In this study in C57BL/6CD14–/– mice and in our previous study, instilling 2 x 105 wild-type macrophages into TLR4-deficient mice (22) showed the same response, that is, significantly elevated total inflammatory cells (Fig. 4A, left), of which the majority are PMN (Fig. 4A, right), but no TNF-{alpha} in whole lung lavage fluid. It is well known that alveolar macrophages are capable of producing TNF-{alpha} when stimulated in culture (31). That we were not able to detect TNF-{alpha} in whole lung lavage from these animals suggests that either 1) these macrophages are not fully functional, or 2) the amount of TNF-{alpha} they are able to produce is below the level of detection of our assays. Our data neither confirm nor refute either possibility. However, the recruitment of PMNs to the lung in both this and our previous study suggests that these macrophages are able to initiate the inflammatory response and hence are normally active. Whether more wild-type macrophages would be required to sustain the response or whether CD14 in this study and TLR4 in our previous study must interact with cells other than macrophages for the progression of the inflammatory response remains to be determined. Likewise, whether more wild-type macrophages would lead to increased AHR in C57BL/6CD14–/– mice also remains to be determined.

In support of the hypothesis that more cell types must interact with CD14 for a whole response to inhaled LPS (inflammatory cells, cytokines, and AHR), epithelial cells, which have been shown to express cell surface CD14 in vitro (14) and ex vivo (4), produce proinflammatory cytokines, release neutrophil chemotactic factors, and increase expression of adhesion molecules on LPS stimulation in vitro. As a model of epithelial cell behavior, it has been shown that A549 cells can release CXC chemokines with neutrophil chemotactic activity on stimulation with TNF-{alpha} or IL-1beta in vitro (25, 37, 38), and primary cultures of human pulmonary epithelial cells also can express IL-8 and other neutrophil chemotactic factors when stimulated with TNF-{alpha} and IL-1beta (7, 25). Supporting the importance of these cells in the response to inhaled LPS, Skerrett et al. (36) have recently demonstrated that selective inhibition of NF-{kappa}B in distal epithelium during an LPS inhalation challenge can attenuate the biological response (neutrophilic inflammation and cytokine production). Cumulatively, these observations suggest complex interactions between cell types required to activate the participating cells to reconstitute the whole physiological and biological response to inhaled endotoxin.

In summary, CD14 is required for the biological response to inhaled endotoxin, and sCD14 can reconstitute the whole (physiological and biological) response to inhaled LPS in the lung. Macrophage expression of CD14 is sufficient to initiate the inflammatory response to inhaled LPS, whereas it appears that CD14 interaction with multiple cell types may be required for progression of this response.


   GRANTS
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
REFERENCES
 
This study was supported by National Institute of Environmental Health Sciences Grants ES-101945, ES-101946, and ES-101947.


   FOOTNOTES
 

Address for reprint requests and other correspondence: D. M. Brass, National Institute of Environmental Health Sciences, Rall Bldg., Rm. C224, P.O. Box 12233 MD C2-15, 111 Alexander Dr., Research Triangle Park, NC 27709 (e-mail: brassd{at}niehs.nih.gov)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


   REFERENCES
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 

  1. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 152: S77–S121, 1995.
  2. Bazil V, Horejsi V, Baudys M, Kristofova H, Strominger JL, Kostka W, Hilgert I. Biochemical characterization of a soluble form of the 53-kDa monocyte surface antigen. Eur J Immunol 16: 1583–1589, 1986.[Web of Science][Medline]
  3. Bazil V, Strominger JL. Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. J Immunol 147: 1567–1574, 1991.[Abstract]
  4. Becker MN, Diamond G, Verghese MW, Randell SH. CD14-dependent lipopolysaccharide-induced beta-defensin-2 expression in human tracheobronchial epithelium. J Biol Chem 275: 29731–29736, 2000.[Abstract/Free Full Text]
  5. Brass DM, Savov JD, Gavett SH, Haykal-Coates N, Schwartz DA. Subchronic endotoxin inhalation causes persistent airway disease. Am J Physiol Lung Cell Mol Physiol 285: L755–L761, 2003.[Abstract/Free Full Text]
  6. Brass DM, Savov JD, Whitehead GS, Maxwell AB, Schwartz DA. LPS binding protein is important in the airway response to inhaled endotoxin. J Allergy Clin Immunol 114: 586–592, 2004.[CrossRef][Web of Science][Medline]
  7. Cromwell O, Hamid Q, Corrigan CJ, Barkans J, Meng Q, Collins PD, Kay AB. Expression and generation of interleukin-8, IL-6 and granulocyte-macrophage colony-stimulating factor by bronchial epithelial cells and enhancement by IL-1 beta and tumour necrosis factor-alpha. Immunology 77: 330–337, 1992.[Web of Science][Medline]
  8. Ferrero E, Jiao D, Tsuberi BZ, Tesio L, Rong GW, Haziot A, Goyert SM. Transgenic mice expressing human CD14 are hypersensitive to lipopolysaccharide. Proc Natl Acad Sci USA 90: 2380–2384, 1993.[Abstract/Free Full Text]
  9. Foster WM, Walters DM, Longphre M, Macri K, Miller LM. Methodology for the measurement of mucociliary function in the mouse by scintigraphy. J Appl Physiol 90: 1111–1117, 2001.[Abstract/Free Full Text]
  10. Frevert CW, Matute-Bello G, Skerrett SJ, Goodman RB, Kajikawa O, Sittipunt C, Martin TR. Effect of CD14 blockade in rabbits with Escherichia coli pneumonia and sepsis. J Immunol 164: 5439–5445, 2000.[Abstract/Free Full Text]
  11. Frey EA, Miller DS, Jahr TG, Sundan A, Bazil V, Espevik T, Finlay BB, Wright SD. Soluble CD14 participates in the response of cells to lipopolysaccharide. J Exp Med 176: 1665–1671, 1992.[Abstract/Free Full Text]
  12. George CL, Jin H, Wohlford-Lenane CL, O'Neill ME, Phipps JC, O'Shaughnessy P, Kline JN, Thorne PS, Schwartz DA. Endotoxin responsiveness and subchronic grain dust-induced airway disease. Am J Physiol Lung Cell Mol Physiol 280: L203–L213, 2001.[Abstract/Free Full Text]
  13. Hailman E, Vasselon T, Kelley M, Busse LA, Hu MC, Lichenstein HS, Detmers PA, Wright SD. Stimulation of macrophages and neutrophils by complexes of lipopolysaccharide and soluble CD14. J Immunol 156: 4384–4390, 1996.[Abstract]
  14. Hamann L, Stamme C, Ulmer AJ, Schumann RR. Inhibition of LPS-induced activation of alveolar macrophages by high concentrations of LPS-binding protein. Biochem Biophys Res Commun 295: 553–560, 2002.[CrossRef][Web of Science][Medline]
  15. Haziot A, Chen S, Ferrero E, Low MG, Silber R, Goyert SM. The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. J Immunol 141: 547–552, 1988.[Abstract]
  16. Haziot A, Ferrero E, Kontgen F, Hijiya N, Yamamoto S, Silver J, Stewart CL, Goyert SM. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity 4: 407–414, 1996.[CrossRef][Web of Science][Medline]
  17. Haziot A, Rong GW, Bazil V, Silver J, Goyert SM. Recombinant soluble CD14 inhibits LPS-induced tumor necrosis factor-alpha production by cells in whole blood. J Immunol 152: 5868–5876, 1994.[Abstract]
  18. Haziot A, Rong GW, Lin XY, Silver J, Goyert SM. Recombinant soluble CD14 prevents mortality in mice treated with endotoxin (lipopolysaccharide). J Immunol 154: 6529–6532, 1995.[Abstract]
  19. Haziot A, Rong GW, Silver J, Goyert SM. Recombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide. J Immunol 151: 1500–1507, 1993.[Abstract]
  20. Hetherington CJ, Kingsley PD, Crocicchio F, Zhang P, Rabin MS, Palis J, Zhang DE. Characterization of human endotoxin lipopolysaccharide receptor CD14 expression in transgenic mice. J Immunol 162: 503–509, 1999.[Abstract/Free Full Text]
  21. Hollingsworth JW 2nd, Cook DN, Brass DM, Walker JK, Morgan DL, Foster WM, Schwartz DA. The role of Toll-like receptor 4 in environmental airway injury in mice. Am J Respir Crit Care Med 170: 126–132, 2004.[Abstract/Free Full Text]
  22. Hollingsworth JW, Chen BJ, Brass DM, Berman K, Gunn MD, Cook DN, Schwartz DA. The critical role of hematopoietic cells in lipopolysaccharide-induced airway inflammation. Am J Respir Crit Care Med 171: 806–813, 2005.[Abstract/Free Full Text]
  23. Jagielo PJ, Quinn TJ, Qureshi N, Schwartz DA. Grain dust-induced lung inflammation is reduced by Rhodobacter sphaeroides diphosphoryl lipid A. Am J Physiol Lung Cell Mol Physiol 274: L26–L31, 1998.[Abstract/Free Full Text]
  24. Jeyaseelan S, Chu HW, Young SK, Freeman MW, Worthen GS. Distinct roles of pattern recognition receptors CD14 and Toll-like receptor 4 in acute lung injury. Infect Immun 73: 1754–1763, 2005.[Abstract/Free Full Text]
  25. Kwon OJ, Au BT, Collins PD, Adcock IM, Mak JC, Robbins RR, Chung KF, Barnes PJ. Tumor necrosis factor-induced interleukin-8 expression in cultured human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 267: L398–L405, 1994.[Abstract/Free Full Text]
  26. Lee JW, Paape MJ, Zhao X. Recombinant bovine soluble CD14 reduces severity of experimental Escherichia coli mastitis in mice. Vet Res 34: 307–316, 2003.[CrossRef][Web of Science][Medline]
  27. Lentsch AB, Ward PA. Regulation of experimental lung inflammation. Respir Physiol 128: 17–22, 2001.[CrossRef][Web of Science][Medline]
  28. Loppnow H, Stelter F, Schonbeck U, Schluter C, Ernst M, Schutt C, Flad HD. Endotoxin activates human vascular smooth muscle cells despite lack of expression of CD14 mRNA or endogenous membrane CD14. Infect Immun 63: 1020–1026, 1995.[Abstract]
  29. Michel O, Duchateau J, Sergysels R. Effect of inhaled endotoxin on bronchial reactivity in asthmatic and normal subjects. J Appl Physiol 66: 1059–1064, 1989.[Abstract/Free Full Text]
  30. Michel O, Kips J, Duchateau J, Vertongen F, Robert L, Collet H, Pauwels R, Sergysels R. Severity of asthma is related to endotoxin in house dust. Am J Respir Crit Care Med 154: 1641–1646, 1996.[Abstract]
  31. Petit C, Monsigny M, Roche AC. Macrophage activation by muramyl dipeptide bound to neoglycoproteins and glycosylated polymers: cytotoxic factor production. J Biol Response Mod 9: 33–43, 1990.[Web of Science][Medline]
  32. Pugin J, Schurer-Maly CC, Leturcq D, Moriarty A, Ulevitch RJ, Tobias PS. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci USA 90: 2744–2748, 1993.[Abstract/Free Full Text]
  33. Read MA, Cordle SR, Veach RA, Carlisle CD, Hawiger J. Cell-free pool of CD14 mediates activation of transcription factor NF-kappa B by lipopolysaccharide in human endothelial cells. Proc Natl Acad Sci USA 90: 9887–9891, 1993.[Abstract/Free Full Text]
  34. Schutt C, Schilling T, Grunwald U, Schonfeld W, Kruger C. Endotoxin-neutralizing capacity of soluble CD14. Res Immunol 143: 71–78, 1992.[CrossRef][Web of Science][Medline]
  35. Schutt C, Schilling T, Kruger C. sCD14 prevents endotoxin inducible oxidative burst response of human monocytes. Allerg Immunol (Leipz) 37: 159–164, 1991.[Medline]
  36. Skerrett SJ, Liggitt HD, Hajjar AM, Ernst RK, Miller SI, Wilson CB. Respiratory epithelial cells regulate lung inflammation in response to inhaled endotoxin. Am J Physiol Lung Cell Mol Physiol 287: L143–L152, 2004.[Abstract/Free Full Text]
  37. Smart SJ, Casale TB. Pulmonary epithelial cells facilitate TNF-alpha-induced neutrophil chemotaxis. A role for cytokine networking. J Immunol 152: 4087–4094, 1994.[Abstract]
  38. Standiford TJ, Kunkel SL, Basha MA, Chensue SW, Lynch JP 3rd, Toews GB, Westwick J, Strieter RM. Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung. J Clin Invest 86: 1945–1953, 1990.[Web of Science][Medline]
  39. Stelter F, Witt S, Furll B, Jack RS, Hartung T, Schutt C. Different efficacy of soluble CD14 treatment in high- and low-dose LPS models. Eur J Clin Invest 28: 205–213, 1998.[CrossRef][Web of Science][Medline]
  40. Su GL, Dorko K, Strom SC, Nussler AK, Wang SC. CD14 expression and production by human hepatocytes. J Hepatol 31: 435–442, 1999.[CrossRef][Web of Science][Medline]
  41. Tasaka S, Ishizaka A, Yamada W, Shimizu M, Koh H, Hasegawa N, Adachi Y, Yamaguchi K. Effect of CD14 blockade on endotoxin-induced acute lung injury in mice. Am J Respir Cell Mol Biol 29: 252–258, 2003.[Abstract/Free Full Text]
  42. Thacker EL. Lung inflammatory responses. Vet Res 37: 469–486, 2006.[CrossRef][Web of Science][Medline]
  43. Walker JK, Peppel K, Lefkowitz RJ, Caron MG, Fisher JT. Altered airway and cardiac responses in mice lacking G protein-coupled receptor kinase 3. Am J Physiol Regul Integr Comp Physiol 276: R1214–R1221, 1999.[Abstract/Free Full Text]
  44. Wohlford-Lenane CL, Deetz DC, Schwartz DA. Cytokine gene expression after inhalation of corn dust. Am J Physiol Lung Cell Mol Physiol 276: L736–L743, 1999.[Abstract/Free Full Text]
  45. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249: 1431–1433, 1990.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
C. L. R. Belmiro, M. T. L. Castelo-Branco, L. M. C. Melim, A. Schanaider, C. Elia, K. Madi, M. S. G. Pavao, and H. S. P. de Souza
Unfractionated Heparin and New Heparin Analogues from Ascidians (Chordate-Tunicate) Ameliorate Colitis in Rats
J. Biol. Chem., April 24, 2009; 284(17): 11267 - 11278.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
C. Pantano, J. L. Ather, J. F. Alcorn, M. E. Poynter, A. L. Brown, A. S. Guala, S. L. Beuschel, G. B. Allen, L. A. Whittaker, M. Bevelander, et al.
Nuclear Factor-{kappa}B Activation in Airway Epithelium Induces Inflammation and Hyperresponsiveness
Am. J. Respir. Crit. Care Med., May 1, 2008; 177(9): 959 - 969.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
N. Kesteman, G. Vansanten, B. Pajak, S. M. Goyert, and M. Moser
Injection of lipopolysaccharide induces the migration of splenic neutrophils to the T cell area of the white pulp: role of CD14 and CXC chemokines
J. Leukoc. Biol., March 1, 2008; 83(3): 640 - 647.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/1/L77    most recent
00282.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brass, D. M.
Right arrow Articles by Schwartz, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brass, D. M.
Right arrow Articles by Schwartz, D. A.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.